Trials / Terminated
TerminatedNCT00378404
Phase I Trial of Docetaxel and Low-Dose Fractionated Radiation in the Treatment of Metastatic or Recurrent NSCLC
A Phase I Trial of Docetaxel and Low-Dose Fractionated Radiation in the Treatment of Metastatic or Recurrent Non-Small Cell Lung Cancer (NSCLC)
- Status
- Terminated
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 10 (actual)
- Sponsor
- Susanne Arnold · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to assess the maximum tolerated dose of low-dose radiation in combination with Docetaxel in recurrent or metastatic non-small cell lung cancer for second-line therapy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Docetaxel | 30 mg/m2 IV on days 1, 8, 15 every 28 days for 6 cycles |
| RADIATION | Radiation | 50 - 80 cGy on days 1, 8, 15 every 28 days for 6 cycles |
Timeline
- Start date
- 2004-11-01
- Primary completion
- 2009-06-01
- Completion
- 2010-01-01
- First posted
- 2006-09-20
- Last updated
- 2015-06-08
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00378404. Inclusion in this directory is not an endorsement.